Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer

Systemic chemotherapy with multiple drug regimens is the main therapy option for advanced gastric cancer (GC) patients. However, many patients develop relapse soon. Here, we evaluated the therapeutic potential of targeting interleukin-8 (IL8) to overcome resistance to chemotherapy in advanced GC. RN...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Huning, Cui, Jiahua, Chu, Hao, Xu, Tingting, Xie, Mengyan, Jing, Xinming, Xu, Jiali, Zhou, Jianwei, Shu, Yongqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055054/
https://www.ncbi.nlm.nih.gov/pubmed/35487914
http://dx.doi.org/10.1038/s41420-022-01033-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055054/
https://www.ncbi.nlm.nih.gov/pubmed/35487914
http://dx.doi.org/10.1038/s41420-022-01033-1

Ejemplares similares